Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of hexaminolevulinate (Hexvix) in
the diagnosis and treatment of patients with non-invasive bladder cancer and if it results in
a change in patient management.